(Press-News.org) A research group led by professor Jesper Ekelund showed that by giving a very large dose of famotidine (200 mg daily), sufficient amounts of the drug are able to penetrate the so-called blood-brain barrier to affect the histamine system in the brain.
Famotidine has been used for the treatment of heartburn since the 1980s, but at regular dosing, famotidine almost does not enter the brain at all, since the brain is protected by the blood-brain barrier. By increasing the dosage five-fold the drug is able to enter the brain and affect the histamine system.
- Already after one week the symptoms of persons suffering from schizophrenia started to decrease and after four weeks of treatment the symptoms had decreased statistically significantly. The patients that participated in the study were also positively disposed towards the treatment, says Ekelund.
Thirty persons suffering from schizophrenia participated in the study. The patients had been on sickness pension for at least five years. They were randomly divided into two groups, one which received famotidine and one which received placebo. All of the patients who took famotidine responded positively to the treatment while the symptoms of those who were on a placebo did not change.
Schizophrenia is the most common and severe psychotic disorder, and is the cause of at least half of all psychiatric hospital treatment days. No randomized, controlled trials in humans that test the effect of H2 blockade in schizophrenia have been published so far.
Innovation in psychiatric medication urgently needed
Since 1963, when the subsequent Nobel prize winner Arvid Carlsson showed that dopamine has a central role in psychosis, the so called dopamine-hypothesis has been central in psychosis. All presently available medications for psychosis are based around this principle. Since treatment response is all too often incomplete and side effects common, there is still a great, unmet medical need for medications with other mechanisms of action. Many other signaling substances have been the focus of attention, but so far, the brain histamine system has most widely been regarded as important only with regard to side effects of many psychosis medications.
- Famotidine shouldn't be used directly as treatment for schizophrenia until long-term use of a dose of this size has been proved safe. However, our study shows that the histamine system in the brain offers a novel approach to treating psychosis. This should lead to increased efforts by the pharmaceutical industry to develop medications based on this histamine-based mechanism, says Ekelund.
Famotidine works by blocking the histamine H2 receptor. There are important neurons in the brain that use histamine as their primary signaling substance. These neurons have an important role as regulators of other signaling substances. From animal research, it is known that by affecting the histamine system, one can also affect other signaling substances that are known to be involved in schizophrenia.
The project has already received international recognition. Katarina Meskanen, one of the members of Ekelunds research group, was awarded the Young Scientist Award of the SCNP (Scandinavian College of Neuropsychopharmacology) and the project has been awarded substantial funding (306,000 USD) from the Stanley foundation for follow-up studies.
INFORMATION:
The research group will replicate the finding through a larger, multinational study in collaboration with Karolinska Institutet in Sweden, where the study is coordinated by professor Jari Tiihonen.
New treatment for schizophrenia discovered in Finland
2013-07-01
ELSE PRESS RELEASES FROM THIS DATE:
Curious mix of precision and brawn in a pouched super-predator
2013-07-01
SYDNEY: A bizarre, pouched super-predator that terrorized South America millions of years ago had huge sabre-like teeth but its bite was weaker than that of a domestic cat, new research shows.
Australian and American marsupials are among the closest living relatives of the extinct Thylacosmilus atrox, which had tooth roots extending rearwards almost into its small braincase.
"Thylacosmilus looked and behaved like nothing alive today," says University of New South Wales palaeontologist, Dr Stephen Wroe, leader of the research team.
"To achieve a kill the animal must have ...
A calculator to estimate the likelihood of antidepressant response
2013-07-01
Philadelphia, PA-- As in any other field of medicine, when a depressed person visits a psychiatrist for treatment of depression, they like to be informed of the odds that they will respond to the medication they are prescribed. Unfortunately, there has been no precise way to predict antidepressant response in individual patients.
It would be very nice to have an equation that would enable doctors to predict the likelihood that individual patients would respond to specific treatments. Accurate predictions are likely to be challenging. The ability to accurately predict ...
Teaching a computer to play concentration advances security, understanding of the mind
2013-07-01
Computer science researchers have programmed a computer to play the game Concentration (also known as Memory). The work could help improve computer security – and improve our understanding of how the human mind works.
The researchers developed a program to get the software system called ACT-R, a computer simulation that attempts to replicate human thought processes, to play Concentration. In the game, multiple matching pairs of cards are placed face down in a random order, and players are asked to flip over two cards, one at a time, to find the matching pairs. If a player ...
Too much of a good thing? Too many 'healing' cells delays wound healing
2013-07-01
Bethesda, MD -- Like most other things, you can have too much of a good thing when it comes to wound healing, and new research proves it. According to an article published in the July 2013 issue of the Journal of Leukocyte Biology, wound healing can be delayed because the body produces too many mast cells, which normally promote healing. An overabundance of these cells, however, also causes harm by leading to the overproduction of IL-10, which prevents certain white blood cells from reaching the wounded area. The work was conducted in mice with lymphedematous skin, and ...
Social responsibility, the main motivation of minority-language radio journalism
2013-07-01
This news release is available in Spanish. The UPV/EHU researcher Irati Agirreazkuenaga-Onaindia has developed a new methodology for studying the profiles, working habits and perceptions of Basque and Scottish Gaelic-speaking radio journalists. The study confirms that social responsibility is the main motivation for the EITB and BBC journalists.
Euskadi Irratia was 30 years old last year, and the study covers what the journalists who work in minority languages are like and how they go about their work. So the UPV/EHU researcher Irati Agirreazkuenaga has compared ...
Breakthrough discovery into the regulation of a key cancer drug target
2013-07-01
There's not much difference between what makes a man and what makes his beer - at least at the molecular level - according to a new study led by Professor John Schwabe at the University of Leicester.
Scientists used a powerful technique called protein crystallography to look at 3D structures of protein complexes purified from cultured human cells. They discovered that a family of complexes, that switch off gene expression, is regulated by small signalling molecules called inositol phosphates.
This latest study shows that this mode of regulation is conserved from yeast ...
Neuroblastoma: Autophagy protects from chemotherapy
2013-07-01
Neuroblastomas are pediatric tumors that originate from cells of the embryonic nervous system. The disease can take widely varying clinical courses that range from spontaneous regression to fatal outcomes. Highly aggressive neuroblastomas rarely respond well to chemotherapy. Understanding and overcoming the resistance mechanisms of highly aggressive neuroblastomas are considered essential to the development of effective treatments.
Scientists from the department headed by Professor Dr. Olaf Witt at the German Cancer Research Center (Deutsches Krebsforschungszentrum, ...
Long-term cannabis use may blunt the brain's motivation system
2013-07-01
Researchers found that dopamine levels in a part of the brain called the striatum were lower in people who smoke more cannabis and those who began taking the drug at a younger age.
They suggest this finding could explain why some cannabis users appear to lack motivation to work or pursue their normal interests.
The study, by scientists at Imperial College London, UCL and King's College London, was funded by the Medical Research Council and published in the journal Biological Psychiatry.
The researchers used PET brain imaging to look at dopamine production in the striatum ...
Researchers discover new way to block inflammation
2013-07-01
Researchers at NYU Langone Medical Center have discovered a mechanism that triggers chronic inflammation in Alzheimer's, atherosclerosis and type-2 diabetes. The results, published today in Nature Immunology, suggest a common biochemical thread to multiple diseases and point the way to a new class of therapies that could treat chronic inflammation in these non-infectious diseases without crippling the immune system. Alzheimer's, atherosclerosis and type-2 diabetes—diseases associated with aging and inflammation—affect more than 100 million Americans.
When the body encounters ...
Study finds biochemical role of crucial TonB protein in bacterial iron transport and pathogenesis
2013-07-01
MANHATTAN, Kan. -- A Kansas State University-led study has discovered the role of a protein in bacteria that cause a wide variety of diseases, including typhoid fever, plague, meningitis and dysentery. The results may lead to new and improved antibiotics for humans and animals.
Phillip E. Klebba, professor and head of the department of biochemistry and molecular biophysics, made the findings with two colleagues in the department: Lorne D. Jordan, doctoral candidate, Manhattan, and Salete M. Newton, research professor. The collaboration included other biophysicists at ...